Carbon-11-methionine PET imaging of malignant melanoma.
暂无分享,去创建一个
[1] K. Någren,et al. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine. , 1995, International journal of radiation oncology, biology, physics.
[2] C. Hoh,et al. Whole body FDG PET imaging for staging of malignant melanoma: Is it cost effective? , 1994 .
[3] A. Buzaid,et al. Role of recombinant interleukin-2 in combination with interferon-alfa and chemotherapy in the treatment of advanced melanoma. , 1993, Seminars in oncology.
[4] H. Miyazawa,et al. PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] M. Senda,et al. Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] R. Wahl,et al. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] A. Veyre,et al. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide). , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] Iwao Kanno,et al. High L‐Methyl‐[11C]Methionine Uptake in Brain Abscess: A PET Study , 1993, Journal of computer assisted tomography.
[9] K. Någren,et al. Carbon-11-methionine and PET in evaluation of treatment response of breast cancer. , 1993, British Journal of Cancer.
[10] S. Pyrhönen,et al. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] K. Ishiwata,et al. Active melanogenesis in non-S phase melanocytes in B16 melanomas in vivo investigated by double-tracer microautoradiography with 18F-fluorodopa and 3H-thymidine. , 1992, British Journal of Cancer.
[12] M. Blend,et al. Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] K. Någren,et al. [11C]methionine quantitation in cancer PET studies. , 1992, Journal of computer assisted tomography.
[14] U Ruotsalainen,et al. Carbon-11-methionine and PET is an effective method to image head and neck cancer. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] R. Wahl,et al. Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography. , 1992, American journal of physiologic imaging.
[16] K. Någren,et al. Uptake of 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. , 1991, British Journal of Cancer.
[17] R Iwata,et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] J. Finkelstein,et al. Methionine metabolism in mammals. , 1990, The Journal of nutritional biochemistry.
[19] R. Hoffman. Unbalanced transmethylation and the perturbation of the differentiated state leading to cancer , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.
[20] Y. Kuwabara,et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. , 1989, Journal of computer assisted tomography.
[21] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] A. Paraf,et al. The role of positron emission tomography in the detection of pancreatic disease. , 1982, Radiology.
[23] J C Briggs,et al. Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.
[24] K. Någren. Quality Control Aspects in the Preparation of [11C]-Methionine , 1993 .
[25] G. Lucignani,et al. MRI, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma. , 1992, Journal of computer assisted tomography.
[26] A. Osterlind. Epidemiology on malignant melanoma in Europe. , 1992, Acta oncologica.
[27] K. Ishiwata,et al. Selective 2-[18F]fluorodopa uptake for melanogenesis in murine metastatic melanomas. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] I. Fidler. The biology of human cancer metastasis , 1991 .
[29] M. Itoh,et al. Differential Diagnosis of Pancreatic Diseases Using PET , 1991 .
[30] J. Eary,et al. Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] D. Carlo,et al. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] S Yoshioka,et al. Lung tumor imaging by positron emission tomography using C-11 L-methionine. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.